The estimated Net Worth of Kevin M Mcnamara is at least $5.24 Millón dollars as of 12 May 2023. Mr. Mcnamara owns over 20,500 units of Luminex Corp stock worth over $4,278,633 and over the last 21 years he sold LMNX stock worth over $761,840. In addition, he makes $198,943 as Independent Director at Luminex Corp.
Sign up
Mr. McNamara LMNX stock SEC Form 4 insiders trading
Kevin has made over 11 trades of the Luminex Corp stock since 2008, according to the Form 4 filled with the SEC. Most recently he bought 20,500 units of LMNX stock worth $1,002,860 on 12 May 2023.
The largest trade he's ever made was exercising 27,500 units of Luminex Corp stock on 29 August 2011 worth over $207,625. On average, Kevin trades about 2,591 units every 93 days since 2004. As of 12 May 2023 he still owns at least 115,670 units of Luminex Corp stock.
You can see the complete history of Mr. Mcnamara stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Kevin McNamara biography
Kevin M. McNamara serves as Independent Director of the Company. Mr. McNamara has served as a member of the Board of Directors since May 2003. In addition, he provided financial and strategic consulting services to the Company from October 2001 through December 2002. Mr. McNamara is a director of Signify Health (formerly known as Censeo Health LLC), a provider of prospective health risk assessments for health plans and healthcare delivery organizations, where he also served as chief executive officer from February 2015 to June of 2018. Mr. McNamara served as executive vice president, chief financial officer and treasurer of HealthSpring, Inc., a managed care company, from April 2005 through May 2009. Mr. McNamara previously served as chief financial officer and a director of HCCA International, Inc., a healthcare management and recruitment company from October 2002 to April 2005. Mr. McNamara currently serves on the board of directors of Tyson. Mr. McNamara is a Certified Public Accountant (inactive) and holds a B.S. in Accounting from Virginia Commonwealth University and a M.B.A. from the University of Richmond. Mr. McNamara brings to the Board of Directors extensive financial expertise, experience managing and growing healthcare industry companies, as well as significant general experience serving on boards and board committees of other public companies. Mr. McNamara’s experience overseeing risk assessment, accounting and financial reporting for public and other healthcare companies provides equally valuable experience in his role as chair of our Audit Committee. Mr. McNamara also has experience overseeing public and private capital markets and mergers and acquisitions transactions.
What is the salary of Kevin McNamara?
As the Independent Director of Luminex Corp, the total compensation of Kevin McNamara at Luminex Corp is $198,943. There are 6 executives at Luminex Corp getting paid more, with Nachum Shamir having the highest compensation of $3,362,140.
How old is Kevin McNamara?
Kevin McNamara is 64, he's been the Independent Director of Luminex Corp since 2003. There are 6 older and 8 younger executives at Luminex Corp. The oldest executive at Luminex Corp is Thomas Erickson, 69, who is the Independent Director.
Insiders trading at Luminex Corp
Over the last 21 years, insiders at Luminex Corp have traded over $55,627,864 worth of Luminex Corp stock and bought 685,936 units worth $10,423,148 . The most active insiders traders include G Walter Ii Loewenbaum, Douglas C Bryant y Laurence E Hirsch. On average, Luminex Corp executives and independent directors trade stock every 26 days with the average trade being worth of $888,944. The most recent stock trade was executed by Harriss T Currie on 1 March 2021, trading 5,325 units of LMNX stock currently worth $97,235.
What does Luminex Corp do?
The mission of Luminex is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. The Company offers a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. Luminex accelerates reliable answers while simplifying complexity and deliver certainty with a seamless experience.
What does Luminex Corp's logo look like?
Complete history of Mr. Mcnamara stock trades at Luminex Corp, Tyson Foods y Signify Health
Luminex Corp executives and stock owners
Luminex Corp executives and other stock owners filed with the SEC include:
-
Nachum Shamir,
President, Chief Executive Officer, Director -
Harriss Currie,
Chief Financial Officer, Senior Vice President - Finance, Treasurer -
Richard Rew,
Senior Vice President, General Counsel and Corporate Secretary -
Todd Bennett,
Senior Vice President - Global Sales and Customer Operations -
Randall Myers,
Senior Vice President - Global Manufacturing and Quality -
Kenneth Samet,
Independent Director -
Kevin McNamara,
Independent Director -
Jimmy Kever,
Independent Director -
Edward Ogunro,
Lead Independent Director -
Thomas Erickson,
Independent Director -
Stephen Eck,
Independent Director -
Dijuana Lewis,
Independent Director -
Eric Shapiro,
Senior Vice President - Global Marketing -
Nancy Fairchild,
Senior Vice President - Human Resources -
Chuck Collins,
Senior Vice President - Research and Development -
Robert J Cresci,
Director -
Tadd S. Lazarus,
SVP, Chief Medical Officer -
Jay B Johnston,
Director -
Russell S Bradley,
VP, Strategic Planning and Bus -
G Walter Ii Loewenbaum,
Director -
Jim D Kever,
Director -
Gregory J Gosch,
Vice President - Marketing -
Charles J. Collins,
SR VP, R&D - US -
John C Carrano,
VP, Research & Development -
J Stark Phd Thompson,
Director -
Douglas C Bryant,
EVP, Chief Operating Officer -
James W Jacobson,
VP, Research & Development -
Oliver H Meek,
VP, Manufacturing -
Randel S Martin,
VP, Marketing/Sales -
Kristi M Richburg,
Controller -
G Walter Ii Loewenbaum,
Director -
C Thomas Caskey,
Director -
Laurence E Hirsch,
Director -
Fred C Jr Goad,
Director -
Jeremy K Bridge Cook,
VP, Luminex Molecular Diagn -
Michael F Pintek,
SVP Operations -
Patrick J Balthrop,
President, Chief Exec. Officer -
Timothy R Dehne,
VP, Systems R&D -
David S Reiter,
General Counsel & Secretary -
Gerard Vaillant,
Director